Systematic Pan-Cancer Analysis Reveals X-C Motif Chemokine Receptor 1 as a Prognostic and Immunological Biomarker
Genes · 2023
DOI: 10.3390/genes14101961 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2023. Verfasst von Likun Cui und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Medical Immunology and Institute of Immunology, Naval Medical University, Shanghai 200433, China. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Peak Disciplines (Type IV) of Institutions of Higher Learning in Shanghai.
Abstract (Originalsprache)
Chemokines and their receptors play an important role in immune monitoring and immune defense during tumor growth and metastasis. However, their prognostic roles in pan-cancer have not been elucidated. In this work, we screened all chemokine receptors in pan-cancer and discovered X-C Motif Chemokine Receptor 1 (XCR1) as a reliable immunological and prognostic biomarker in pan-cancer using bioinformation. The TCGA database served as the foundation for the primary research database analysis in this work. XCR1 was downregulated in tumors. Patients with reduced XCR1 showed worse prognoses and a concomitant decrease in immune cell infiltration (DCs and CD8+ T cells). According to a gene enrichment study, XCR1 enhanced immune system performance by promoting T-cell infiltration through the C-X-C Motif Chemokine Ligand 9 (CXCL9)- C-X-C Motif Chemokine Receptor 3 (CXCR3) axis. In addition, XCR1 is mainly expressed in infiltrated DCs and some malignant cells in tumor tissues. Our data revealed the important role of XCR1 in remodeling the tumor microenvironment and predicting the survival prognosis, which could also be used as a sensitive biomarker for tumor immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Medical Immunology and Institute of Immunology, Naval Medical University, Shanghai 200433, China.
- Shanghai Institute of Stem Cell Research and Clinical Translation, Shanghai 200120, China.
ORCID-Profile: Likun Cui
Förderung
- National Natural Science Foundation of China
- Peak Disciplines (Type IV) of Institutions of Higher Learning in Shanghai
Zitieren
APA
Cui, L., Zhu, L., Chen, J., Li, C., Yu, Y., & Xu, S. (2023). Systematic Pan-Cancer Analysis Reveals X-C Motif Chemokine Receptor 1 as a Prognostic and Immunological Biomarker. Genes. https://doi.org/10.3390/genes14101961
Vancouver
Cui L, Zhu L, Chen J, Li C, Yu Y, Xu S. Systematic Pan-Cancer Analysis Reveals X-C Motif Chemokine Receptor 1 as a Prognostic and Immunological Biomarker. Genes. 2023. doi:10.3390/genes14101961
BibTeX
@article{Cui2023,
author = {Cui, Likun and Zhu, Liye and Chen, Jie and Li, Chunzhen and Yu, Yizhi and Xu, Sheng},
title = {Systematic Pan-Cancer Analysis Reveals X-C Motif Chemokine Receptor 1 as a Prognostic and Immunological Biomarker},
journal = {Genes},
year = {2023},
doi = {10.3390/genes14101961}
}
EUVIMED